Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_assertion description "[Compounds that inhibit kinase activity are effective growth inhibitors for poorly differentiated thyroid cancer cell lines with either RET or RAF mutations, and hold promise for treatment of most forms of papillary thyroid carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_assertion evidence source_evidence_literature NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_assertion SIO_000772 16551863 NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_assertion wasDerivedFrom befree-2016 NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_assertion wasGeneratedBy ECO_0000203 NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.
- befree-2016 importedOn "2016-02-19" NP541379.RA0BoFd1EGDtZqx1SajJUnmWDiJkvj3cH0ppEbIik0etY130_provenance.